"Focus On Vaccinating Kids With Co-Morbidities First": AIIMS Chief
"While vaccinating children, we must first focus on children with co-morbidities who have a higher chance of developing serious COVID-19 infections," says Dr Randeep Guleria, Director of AIIMS after India's expert panel approves Covaxin jabs for children between the ages of 2-18. Regulatory approval for Covaxin for children is still awaited.
